Published in J Womens Health (Larchmt) on November 06, 2013
Capsule Commentary on Haas et al., Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med (2016) 0.75
Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations. J Womens Health (Larchmt) (2016) 0.75
Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav (1995) 38.24
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev (1994) 11.74
Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med (2002) 8.18
Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin (2007) 4.09
Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) (2008) 3.02
Reported drop in mammography : is this cause for concern? Cancer (2007) 2.91
Older adults and forgoing cancer screening: "I think it would be strange". JAMA Intern Med (2013) 2.08
Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev (2007) 2.02
Factors associated with women's adherence to mammography screening guidelines. Health Serv Res (1998) 1.87
Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin (2007) 1.77
The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women? J Womens Health (Larchmt) (2012) 1.65
Methodological issues in using multiple years of the Medicare current beneficiary survey. Medicare Medicaid Res Rev (2012) 1.58
Cancer screening in the older patient. Am Fam Physician (2008) 1.53
Interval adherence to mammography screening guidelines. Med Care (1991) 1.49
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35
Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med (2007) 1.31
Screening for cervical cancer: recommendations and rationale. Am J Nurs (2003) 1.25
Physician recommendation for papanicolaou testing among U.S. women, 2000. Cancer Epidemiol Biomarkers Prev (2005) 1.22
Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med Care (2011) 1.10
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
Utilization of screening mammography--1990. Womens Health Issues (1991) 1.01
Improving the delivery of preventive services to Medicare beneficiaries. JAMA (2009) 1.00
Prioritizing clinical preventive services: a review and framework with implications for community preventive services. Annu Rev Public Health (2009) 0.99
Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Med Care (2008) 0.98
Predictors of mammography use among women veterans. J Womens Health (1998) 0.97
Comparison between US Preventive Services Task Force recommendations and Medicare coverage. Ann Fam Med (2011) 0.94
Predictors of preventive service use among Medicare beneficiaries. Health Care Financ Rev (2006) 0.88
Severing the link between coverage policy and the US Preventive Services Task Force. JAMA (2013) 0.88
Self-referral for screening mammography. J Gen Intern Med (1998) 0.88
Cervical cancer screening among women by hysterectomy status and among women aged ≥65 years - United States, 2000-2010. MMWR Morb Mortal Wkly Rep (2013) 0.86
Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts. J Natl Cancer Inst Monogr (2005) 0.86
Serious health events and discontinuation of routine cancer screening. Med Decis Making (2012) 0.84
Low health literacy and health outcomes: an updated systematic review. Ann Intern Med (2011) 16.08
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA (2012) 5.90
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Promoting informed choice: transforming health care to dispense knowledge for decision making. Ann Intern Med (2005) 3.34
Health literacy interventions and outcomes: an updated systematic review. Evid Rep Technol Assess (Full Rep) (2011) 3.24
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med (2010) 2.36
Global risk of coronary heart disease: assessment and application. Am Fam Physician (2010) 2.21
Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer (2010) 2.15
Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol (2012) 1.81
Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol (2011) 1.68
The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women? J Womens Health (Larchmt) (2012) 1.65
Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy. JAMA Intern Med (2013) 1.60
Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. Cancer (2013) 1.56
Choosing Healthplans All Together: a deliberative exercise for allocating limited health care resources. J Health Polit Policy Law (2005) 1.53
Will insured citizens give up benefit coverage to include the uninsured? J Gen Intern Med (2004) 1.49
Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. BMC Health Serv Res (2012) 1.44
Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer. Cancer (2014) 1.40
Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst (2012) 1.39
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control (2006) 1.38
Estimating the Cost of Early Infant Male Circumcision in Zimbabwe: Results From a Randomized Noninferiority Trial of AccuCirc Device Versus Mogen Clamp. J Acquir Immune Defic Syndr (2015) 1.35
Insurance benefit preferences of the low-income uninsured. J Gen Intern Med (2002) 1.32
Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology (2013) 1.30
Cost-effectiveness of adding bed net distribution for malaria prevention to antenatal services in Kinshasa, Democratic Republic of the Congo. Am J Trop Med Hyg (2009) 1.21
Building community capacity to participate in cancer prevention research. Cancer Control (2006) 1.20
Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan (2013) 1.20
Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer (2007) 1.17
Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening. J Gen Intern Med (2011) 1.17
Global Noncommunicable Disease Research: Opportunities and Challenges. Ann Intern Med (2015) 1.15
"Not the 'grim reaper service'": an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc (2014) 1.14
Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat (2011) 1.13
Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention. Prev Cardiol (2004) 1.13
Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control (2009) 1.12
Adapting clinical trials networks to promote cancer prevention and control research. Cancer (2006) 1.10
Diverging racial and ethnic disparities in access to physician care: comparing 2000 and 2007. Med Care (2012) 1.10
Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak (2013) 1.08
Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res (2011) 1.08
The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy. Med Care (2008) 1.07
Using claims-based measures to predict performance status score in patients with lung cancer. Cancer (2010) 1.05
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer (2012) 1.05
Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf (2013) 1.05
Enrollees choose priorities for Medicare. Gerontologist (2004) 1.04
Use and timeliness of radiation therapy after breast-conserving surgery in low-income women with early-stage breast cancer. Cancer Invest (2012) 1.00
An examination of Alzheimer's disease case definitions using Medicare claims and survey data. Alzheimers Dement (2010) 0.99
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy. Lung Cancer (2012) 0.98
Kappa statistic for clustered dichotomous responses from physicians and patients. Stat Med (2013) 0.97
Self-insurance in times of growing and retreating managed care. Health Aff (Millwood) (2003) 0.97
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res Treat (2012) 0.95
Why don't people buy long-term-care insurance? J Gerontol B Psychol Sci Soc Sci (2006) 0.95
Examining potential colorectal cancer care disparities in the Veterans Affairs health care system. J Clin Oncol (2013) 0.95
Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions. Am J Prev Med (2008) 0.93
Managed care and employer premiums. Int J Health Care Finance Econ (2003) 0.92
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer (2011) 0.92
The long-term cost effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics (2006) 0.92
Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer. J Natl Cancer Inst (2008) 0.91
Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer. Breast Cancer Res Treat (2011) 0.89
Data for cancer comparative effectiveness research: past, present, and future potential. Cancer (2012) 0.89
Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis. Value Health (2011) 0.88
Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy. Cancer (2013) 0.87
Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapy. Med Care (2011) 0.87
Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients. Breast Cancer Res Treat (2011) 0.87
Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis. J Geriatr Oncol (2013) 0.87
The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project. J Natl Med Assoc (2013) 0.86
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study. Cancer (2008) 0.86
Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer. J Pain Symptom Manage (2010) 0.86
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. BJU Int (2006) 0.86
The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios. Pharmacoeconomics (2004) 0.85
Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending? Health Serv Res (2013) 0.85
Differential receipt of sentinel lymph node biopsy within practice-based research networks. Med Care (2013) 0.85
Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. Infect Control Hosp Epidemiol (2012) 0.85
Short-term costs associated with primary prophylactic G-CSF use during chemotherapy. Am J Manag Care (2013) 0.84
The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer. Cancer Manag Res (2013) 0.84
Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005. J Thorac Oncol (2014) 0.84
Is medical home enrollment associated with receipt of guideline-concordant follow-up care among low-income breast cancer survivors? Med Care (2013) 0.84
Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Clin Ther (2008) 0.83
Patient-physician agreement on the content of CHD prevention discussions. Health Expect (2011) 0.83
Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer. Am J Clin Oncol (2014) 0.83
Risk adjustment for Medicare beneficiaries with Alzheimer's disease and related dementias. Am J Manag Care (2010) 0.82
Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study. Breast Cancer Res Treat (2013) 0.82
Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer. Breast Cancer Res Treat (2010) 0.82
A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med (2003) 0.82
Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis. Med Decis Making (2009) 0.81
The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias. Med Care (2009) 0.81
An overview of methods for comparative effectiveness research. Semin Radiat Oncol (2014) 0.81
Beyond toxicity: the challenge and importance of understanding the full impact of treatment decisions. Cancer (2009) 0.81
Payment generosity and physician acceptance of Medicare and Medicaid patients. Int J Health Care Finance Econ (2014) 0.81
Use of 2001-2002 Behavioral Risk Factor Surveillance System data to characterize cancer survivors in North Carolina. N C Med J (2011) 0.80
Tables or bar graphs? Presenting test results in electronic medical records. Med Decis Making (2012) 0.80
Medicare Part B reimbursement and the perceived quality of physician care. Int J Health Care Finance Econ (2009) 0.80
Health effects of managed care among the near-elderly. J Aging Health (2006) 0.80